Drug Recalls
Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.
Bell Pharmaceuticals, Inc
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
Bell Pharmaceuticals, Inc
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
Bell Pharmaceuticals, Inc
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
Bell Pharmaceuticals, Inc
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
Bell Pharmaceuticals, Inc
SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).
Reliance Life Sciences Private Limited
Lack of Sterility Assurance
Reliance Life Sciences Private Limited
Lack of Sterility Assurance
Reliance Life Sciences Private Limited
Lack of Sterility Assurance
Reliance Life Sciences Private Limited
Lack of Sterility Assurance
QuVa Pharma, Inc.
Failed Impurities/Degradation Specifications
JB Chemicals and Pharmaceuticals Ltd
Cross Contamination with Other Products: Customer complaints for appearance of discolored tablets and red dots observed on Cetirizine Hydrochloride Tablets USP…
Padagis US LLC
Subpotent Drug: Low out of specification assay results performed during long-term stability testing.
Direct Rx
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
SUN PHARMACEUTICAL INDUSTRIES INC
Labeling: Label Mix-up: 10mg Perampanel CIII tablet was found in a Perampanel CIII bottle labeled Perampanel 6 mg tablets.
Polyflex 25 g/vial powder for suspension
Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…
The Harvard Drug Group LLC
Subpotent Drug
Lancora 5 mg tablet
Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…
Par Health USA, LLC
Crystallization; identified as Buprenorphine free base
Boehringer Ingelheim Pharmaceuticals, Inc.
CGMP Deviations: An incorrect detergent was used and the required swab sampling was not performed on a production hopper that had previously been used for a dif…
CareFusion 213, LLC
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to cus…
CareFusion 213, LLC
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to cus…
CareFusion 213, LLC
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to cus…
CareFusion 213, LLC
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to cus…
CareFusion 213, LLC
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to cus…
CareFusion 213, LLC
Lack of assurance of sterility: Unsterilized ChloraPrep & PurPrep Applicators, intended for further processing and sterilization were instead distributed to cus…